Product Program year 2025 Source: CMS Open Payments

Velys

Device Ortho-Knee

PDI 10603295519515

Open in the dashboard

General payments

$2,639,018

7,702 payments

Research payments

$242,644

148 payments

Through program year 2025, $2,639,018 in general payments and $242,644 in research payments were reported against Velys (Ortho-Knee).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

9 rows
Year Kind Amount Payments
2025 General $904,523 1,920
2025 Research $53,171 140
2024 General $715,758 1,778
2024 Research $15,730 3
2023 General $639,648 1,341
2023 Research $52,174 4
2022 General $145,299 895
2022 Research $121,569 1
2021 General $233,791 1,768

Breakdown

Who paid General payments · program years 2021–2025
  1. Medical Device Business Services, Inc. $1,945,198 3,295 payments
  2. DePuy Synthes Products, Inc. $402,260 1,342 payments
  3. DePuy Synthes Sales Inc. $260,623 3,024 payments
  4. Ethicon Inc. $16,088 7 payments
  5. Ethicon US, LLC $5,739 5 payments
  6. Johnson & Johnson Health Care Systems Inc. $5,056 6 payments
  7. Ethicon Endo-Surgery Inc. $3,570 1 payment
  8. Johnson and Johnson International $485 22 payments
Top recipients General payments · program year 2025
  1. Sayfe Jassim Orthopaedic Surgery · Omaha, NE $120,239 13% · 48 payments
  2. Ryan Nunley Adult Reconstructive Orthopaedic Surgery · Saint Louis, MO $91,891 10% · 31 payments
  3. Peter Chalmers Orthopaedic Surgery · Saint Louis, MO $74,103 8% · 19 payments
  4. Philip Huang Orthopaedic Surgery · Carmel, IN $65,988 7% · 35 payments
  5. Alexander Athey Orthopaedic Surgery · New Albany, OH $46,166 5% · 20 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Orthopaedic Surgery $640,421 71% · 321 practitioners
  2. Adult Reconstructive Orthopaedic Surgery Orthopaedic Surgery $191,959 21% · 60 practitioners
  3. Orthopaedic Trauma Orthopaedic Surgery $28,639 3% · 5 practitioners
  4. Neurological Surgery $20,596 2% · 65 practitioners
  5. Orthopaedic Surgery of the Spine Orthopaedic Surgery $10,667 1% · 52 practitioners

The top 5 of 30 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Missouri $184,906 20% · 19 recipients
  2. Nebraska $120,764 13% · 3 recipients
  3. Florida $106,552 12% · 32 recipients
  4. Indiana $76,379 8% · 11 recipients
  5. California $55,111 6% · 37 recipients

The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

7,702 general · 148 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record